Non-alcoholic fatty liver disease Archives

Patient Care

Genetic Variation in MASLD Suggests Precision Treatment Approaches

Chris Anderson -

September 28, 2023

Illustration of a man's torso and arms with his liver highlighted in red to indicate acute liver failure

News & Features

How B Cells Boost Liver Cancer Development

Christina Jackson -

May 24, 2023

Nutritionist calculating body mass index of woman for obesity treatment in a clinic room.

News & Features

Lipidio Raises $20M Series A for Dermatological and Metabolic Diseases

Malorye Branca -

November 14, 2022

News & Features

Decreases in Enzyme Linked to Nonalcoholic Fatty Liver Disease

Chris Anderson -

August 23, 2022

A conceptual illustration of Fatty liver cells in the shape of a liver

News & Features

Type 2 Diabetes Risk Increased by Pediatric Liver Disease

John Sterling -

June 15, 2022

News & Features

NASH Study Reveals New Potential Therapy

Malorye Branca -

December 17, 2021

News & Features

TGen Study Pinpoints Biomarkers for Non-Alcoholic Fatty Liver Disease

Malorye Branca -

September 20, 2021

Molecular Dx

RNA Modification May Protect Against Nonalcoholic Fatty Liver Disease

Christina Jackson -

July 21, 2021

News & Features

Promising New Liver Disease Diagnostic Analyzes Microbiome from Stool Samples

Malorye Branca -

July 2, 2020

News & Features

ProSciento, Nordic Bioscience Partner to Develop Translational Biomarkers for NASH

Alex Philippidis -

February 6, 2020

AbbVie Buys ImmunoGen for $10.1B to Speed Entry into Ovarian Cancer…

Biological Robots Show Healing Potential

ACC and AHA Issue New Guideline for Preventing and Optimally Managing…

Slow Brain Waves: A Natural Shield against Epileptic Activity

Nasal Swab Test Separates High- from Low-Risk Lung Cancer Polyps

Non-alcoholic fatty liver disease

Genetic Variation in MASLD Suggests Precision Treatment Approaches

How B Cells Boost Liver Cancer Development

Lipidio Raises $20M Series A for Dermatological and Metabolic Diseases

Decreases in Enzyme Linked to Nonalcoholic Fatty Liver Disease

Type 2 Diabetes Risk Increased by Pediatric Liver Disease

NASH Study Reveals New Potential Therapy

TGen Study Pinpoints Biomarkers for Non-Alcoholic Fatty Liver Disease

RNA Modification May Protect Against Nonalcoholic Fatty Liver Disease

Promising New Liver Disease Diagnostic Analyzes Microbiome from Stool Samples

ProSciento, Nordic Bioscience Partner to Develop Translational Biomarkers for NASH

Related Content

Oxford Nanopore and Genomics England to Sequence 7,500 Samples for Rare Disease Initiative

Largest GWAS Meta-Analysis of Suicide Attempt Highlights 12 Risk Loci

First Blood Test for Dozens of Hereditary Cancers Approved by FDA

Some Women Could Avoid Genetic Counseling Before/After Cancer Genetic Testing